【4565】ネクセラファーマ
創薬。本社は大阪府。
類似企業:
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023.12 | 2024/02/13 | 実 | 12,766 | - | - | - | -9,526 | - | - | - | -10,680 | - | - | - | -7,193 | - | - | - |
2022.12 | 2023/02/14 | 実 | 15,569 | - | - | - | 3,436 | - | - | - | 1,078 | - | - | - | 382 | - | - | - |
2021.12 | 2022/02/10 | 実 | 17,712 | - | - | - | 3,775 | - | - | - | 433 | - | - | - | 1,017 | - | - | - |
2020.12 | 2021/02/12 | 実 | 8,842 | - | - | - | 928 | - | - | - | 1,622 | - | - | - | 1,479 | - | - | - |
2019.12 | 2020/02/13 | 実 | 9,726 | - | - | - | 384 | - | - | - | 534 | - | - | - | 1,432 | - | - | - |
2018.12 | 2019/02/12 | 実 | 2,872 | ↑ | - | - | -5,734 | - | - | - | -7,243 | ↓ | - | - | -5,977 | ↓ | - | - |
2018.12 | 2018/05/10 | 当初予 | 0 | - | - | - | - | - | - | - | 0 | - | - | - | 0 | - | - | - |
2018.03 | 2018/05/10 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2017.03 | 2017/05/12 | 実 | 18,901 | ↓ | -2.7% | -32.3% | 12,389 | ↓ | -0.3% | -27.5% | 12,483 | ↓ | -16.2% | -16.2% | 9,311 | ↓ | -28.7% | -28.7% |
2017.03 | 2017/02/10 | Q3予 | 19,426 | ↓ | -30.4% | -30.4% | 12,431 | ↓ | -27.3% | -27.3% | - | - | - | - | - | - | - | - |
2017.03 | 2016/11/14 | Q2予 | 27,925 | → | 0.0% | 0.0% | 17,096 | → | 0.0% | 0.0% | 14,901 | → | 0.0% | 0.0% | 13,064 | → | 0.0% | 0.0% |
2017.03 | 2016/08/10 | Q1予 | 27,925 | → | 0.0% | 0.0% | 17,096 | → | 0.0% | 0.0% | 14,901 | → | 0.0% | 0.0% | 13,064 | → | 0.0% | 0.0% |
2017.03 | 2016/05/13 | 当初予 | 27,925 | - | - | - | 17,096 | - | - | - | 14,901 | - | - | - | 13,064 | - | - | - |
2016.03 | 2016/05/13 | 実 | 8,151 | ↓ | -0.9% | -30.5% | 1,075 | ↑ | +132.3% | -81.8% | -3,297 | ↑ | +1.0% | -155.7% | -1,432 | ↑ | +58.4% | -123.7% |
2016.03 | 2016/04/07 | 修正予 | 8,228 | ↓ | -29.9% | -29.9% | -3,331 | ↓ | -156.5% | -156.5% | -3,331 | ↓ | -156.3% | -156.3% | -3,444 | ↓ | -157.0% | -157.0% |
2016.03 | 2016/02/10 | Q3予 | 11,732 | → | 0.0% | 0.0% | 5,899 | → | 0.0% | 0.0% | 5,915 | → | 0.0% | 0.0% | 6,047 | → | 0.0% | 0.0% |
2016.03 | 2015/11/12 | Q2予 | 11,732 | → | 0.0% | 0.0% | 5,899 | → | 0.0% | 0.0% | 5,915 | → | 0.0% | 0.0% | 6,047 | → | 0.0% | 0.0% |
2016.03 | 2015/08/12 | Q1予 | 11,732 | → | 0.0% | 0.0% | 5,899 | → | 0.0% | 0.0% | 5,915 | → | 0.0% | 0.0% | 6,047 | → | 0.0% | 0.0% |
2016.03 | 2015/05/13 | 当初予 | 11,732 | - | - | - | 5,899 | - | - | - | 5,915 | - | - | - | 6,047 | - | - | - |
2015.03 | 2015/05/13 | 実 | 3,671 | ↑ | +11.2% | +11.2% | 1,108 | ↓ | -44.6% | -44.6% | 1,366 | ↓ | -31.7% | -31.7% | 568 | ↓ | -71.6% | -71.6% |
2015.03 | 2015/02/12 | Q3予 | 3,300 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% |
2015.03 | 2014/11/11 | Q2予 | 3,300 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% |
2015.03 | 2014/08/13 | Q1予 | 3,300 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% |
2015.03 | 2014/06/25 | FY予 | 3,300 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% |
2015.03 | 2014/05/13 | 当初予 | 3,300 | - | - | - | 2,000 | - | - | - | 2,000 | - | - | - | 2,000 | - | - | - |
2014.03 | 2014/06/25 | 実 | 2,069 | → | 0.0% | 0.0% | 756 | ↑ | +163.8% | +163.8% | 737 | ↑ | +169.2% | +169.2% | 1,526 | ↑ | +1350.8% | +1350.8% |
2014.03 | 2014/05/13 | 実 | 2,069 | - | - | - | -1,185 | - | - | - | -1,065 | - | - | - | -122 | - | - | - |